Indexed In
- Open J Gate
- Genamics JournalSeek
- Academic Keys
- JournalTOCs
- China National Knowledge Infrastructure (CNKI)
- Ulrich's Periodicals Directory
- RefSeek
- Hamdard University
- EBSCO A-Z
- Directory of Abstract Indexing for Journals
- OCLC- WorldCat
- Publons
- Geneva Foundation for Medical Education and Research
- Euro Pub
- Google Scholar
Useful Links
Share This Page
Journal Flyer
Open Access Journals
- Agri and Aquaculture
- Biochemistry
- Bioinformatics & Systems Biology
- Business & Management
- Chemistry
- Clinical Sciences
- Engineering
- Food & Nutrition
- General Science
- Genetics & Molecular Biology
- Immunology & Microbiology
- Medical Sciences
- Neuroscience & Psychology
- Nursing & Health Care
- Pharmaceutical Sciences
Articles published in Journal of Stem Cell Research & Therapy have been cited by esteemed scholars and scientists all around the world. Journal of Stem Cell Research & Therapy has got h-index 33, which means every article in Journal of Stem Cell Research & Therapy has got 33 average citations.
Following are the list of articles that have cited the articles published in Journal of Stem Cell Research & Therapy.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Total published articles |
22 | 58 | 59 | 65 | 23 | 13 | 36 | 34 | 49 | 63 | 101 | 62 | 44 | 26 |
Research, Review articles and Editorials |
2 | 4 | 1 | 2 | 12 | 12 | 29 | 28 | 44 | 56 | 80 | 48 | 12 | 19 |
Research communications, Review communications, Editorial communications, Case reports and Commentary |
20 | 54 | 58 | 63 | 11 | 1 | 7 | 6 | 5 | 7 | 21 | 14 | 32 | 6 |
Conference proceedings |
0 | 40 | 12 | 37 | 0 | 0 | 145 | 138 | 95 | 63 | 154 | 72 | 54 | 0 |
Citations received as per Google Scholar, other indexing platforms and portals |
522 | 678 | 761 | 838 | 697 | 626 | 613 | 599 | 538 | 478 | 262 | 142 | 31 | 69 |
| Journal total citations count | 6793 |
| Journal impact factor | 1.64 |
| Journal 5 years impact factor | 1.70 |
| Journal cite score | 11.56 |
| Journal h-index | 33 |
Important citations
Conducting Value for Money Analyses for Non-randomised Interventional Studies Including Service Evaluations: An Educational Review with Recommendations
Law and Economics of Personalized Medicine
Pediatric Vaccines and Cost-Effectiveness Thresholds: How Much is Too Much to Pay for Prevention?
Economic evaluations in paediatric dentistry clinical trials
Economic evaluation of orphan drug Lutetium-Octreotate vs. Octreotide long-acting release for patients with an advanced midgut neuroendocrine tumour in the Netherlands
Application of economic analysis to evaluate various infectious diseases in Vietnam
A systematic evaluation of paediatric allergy pathways in the West Midlands
Economic evaluation: its role and value for healthcare decision-making
Patient-Centered Approach to Benefit–Risk Characterization Using Number Needed to Benefit and Number Needed to Harm: Advanced Non–Small-Cell Lung Cancer
Economic Evaluation of Interventions in Parkinson’s disease - A Systematic Literature Review
Value-based health-care principles in health-care organizations
THE METAPHYSICAL-ETHICAL ERRORS OF PRISON PRIVATIZATION
Maintaining Clinical Freedom Whilst Achieving Value in Biologics Prescribing: An Integrated Cross-Specialty Consensus of UK Dermatologists, Rheumatologists and Gastroenterologists
How cost-effective is nutrition care delivered in primary healthcare settings? A systematic review of trial-based economic evaluations
MILITARY VETERAN TRANSITION INTO EMPLOYMENT AND CIVILIAN ENGAGEMENT: A WALKING WITH THE WOUNDED EVALUATION
Economic evaluation of home medication review by community pharmacists (HMR-CP) for patients with type 2 diabetes mellitus (T2DM)
QUOTATIONS TO OPEN ON
An Introduction to the Main Types of Economic Evaluations Used for Informing Priority Setting and Resource Allocation in Healthcare: Key Features, Uses, and Limitations
MODERN TREATMENT OF MULTIPLE MYELOMA IN RELAPSED AND REFRACTORY PATIENTS. CAN WE PAY THE PRICE?
MODERN TREATMENT OF MULTIPLE MYELOMA IN RELAPSED AND REFRACTORY PATIENTS. CAN WE PAY THE PRICE?